NUCLEIC ACIDS RESEARCH, published by Oxford University Press, is a premier peer-reviewed journal in the field of genetics, holding a prestigious Q1 ranking in this domain as of 2023. Since its inception in 1974 and with a converged publication horizon extending to 2024, this journal has established itself as a vital resource for researchers and professionals interested in the molecular aspects of nucleic acids, encompassing DNA and RNA studies as well as their implications in biochemistry and molecular biology. With an impressive Scopus rank of #6 out of 347 in Genetics, this journal is positioned in the 98th percentile among its peers, highlighting its significant impact and relevance in the scientific community. As an open access journal since 2005, NUCLEIC ACIDS RESEARCH ensures wide dissemination of knowledge, promoting collaborative advancements in genetic research. For those looking to stay at the forefront of nucleic acid research, this journal remains an essential publication for accessing cutting-edge findings and innovative methodologies in the field.

International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.

Horticulture Research, published by Oxford University Press Inc, is a leading open-access journal dedicated to advancing knowledge in the fields of horticulture, plant science, and related biotechnological disciplines. Since its inception in 2014, the journal has rapidly established itself as a premier outlet for research, boasting prestigious Q1 rankings across multiple categories including Biochemistry, Biotechnology, Genetics, Horticulture, and Plant Science in 2023. With exceptional Scopus rankings—placing it in the top 2% of Horticulture journals and 4% for Plant Science globally—Horticulture Research provides a vital platform for scholars, professionals, and students to disseminate and engage with innovative findings. Emphasizing the importance of open accessibility, the journal allows for widespread dissemination of impactful research, making it an invaluable resource for those striving to enhance sustainable horticultural practices and plant-based innovations. Its aim to bridge the gap between theoretical study and practical application reflects the dynamic nature of the horticultural sciences today.

CURRENT GENE THERAPY is a leading journal in the field of gene therapy, offering a platform for researchers and professionals to publish their findings related to innovative approaches in gene-based treatments. Published by Bentham Science Publishers Ltd, this journal, with its ISSN 1566-5232 and E-ISSN 1875-5631, is indexed in respected databases, enhancing its visibility and impact in the scientific community. As of 2023, it holds a commendable impact factor, with categorized quartile rankings reflecting its influence, especially in Drug Discovery (Q2), Genetics (Q3), and Molecular Medicine (Q3). Although it follows a subscription model, the journal aims to bridge the gap between laboratory research and clinical applications, attracting submissions that provide critical insights into gene therapy advancements from 2001 to 2024. The editorial scope covers various aspects of gene therapy, including experimental studies and clinical trials, underlining its commitment to fostering knowledge that addresses genetic disorders and enhances therapeutic efficacy. Whether you are a researcher, clinician, or student, CURRENT GENE THERAPY serves as an invaluable resource at the forefront of genetic research and medical innovation.

Frontiers in Genome Editing, published by FRONTIERS MEDIA SA, stands at the forefront of genomic research, specializing in the rapidly evolving realm of gene editing technologies. With an enthusiastic commitment to open access since 2020, this journal facilitates unrestricted distribution of cutting-edge research, making significant advancements in biotechnology and genetics accessible to a global audience. Located in Lausanne, Switzerland, Frontiers in Genome Editing publishes high-quality, peer-reviewed articles that contribute to the understanding and application of genome editing tools, such as CRISPR and TALEN, in various biological fields. Notably, as of 2023, the journal holds a prestigious Q1 ranking in Biotechnology and a Q2 ranking in Genetics, underscoring its importance and influence within these disciplines. With robust Scopus rankings, including a notable percentile placement, Frontiers in Genome Editing is an invaluable resource for researchers, professionals, and students dedicated to the promising future of genomic innovation.

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

NEW PHYTOLOGIST is a premier international journal published by WILEY, focusing on the field of plant science and physiology. Operating since 1902, this esteemed journal has established itself as a vital resource for researchers and professionals alike, offering cutting-edge research and insights into the complex workings of plants and their physiological processes. With an impressive impact factor and recognized in the top quartile (Q1) of both the physiology and plant science categories, it ranks #8 and #9 respectively in their fields, placing it within the top 2% of journals. NEW PHYTOLOGIST is not only essential for enhancing the understanding of plant biology but also for addressing global challenges such as food security and environmental sustainability. Although it does not currently offer open access, the journal remains committed to disseminating knowledge to a wide audience through institutional subscriptions and partnerships. This journal continues to drive advancements in plant science into the future, making it an invaluable asset for students, researchers, and industry professionals.

TRANSGENIC RESEARCH, an esteemed academic journal published by Springer, has been at the forefront of the fields of agronomy, animal science, and biotechnology since its inception in 1991. With an ISSN of 0962-8819 and an E-ISSN of 1573-9368, this journal is pivotal in disseminating cutting-edge research and innovative methodologies that pave the way for advancements in genetic engineering and transgenic technology. Ranked in the Q2 category for Agronomy and Crop Science, Animal Science and Zoology, and Biotechnology, and within the top 90th percentile in Scopus for several related categories, TRANSGENIC RESEARCH maintains a prominent position in the global scientific community. This journal serves as a vital resource for researchers, professionals, and students, providing a platform for papers that explore both fundamental and applied aspects of transgenic research, ultimately contributing to sustainable agricultural practices and environmental stewardship. The journal’s commitment to fostering dialogue and collaboration among experts makes it an essential read for anyone interested in pushing the boundaries of genetic research.

GENETICS AND MOLECULAR BIOLOGY, published by the SOC BRASIL GENETICA, is a prominent journal dedicated to the advancement of knowledge in the fields of genetics and molecular biology. Since its inception in 1998, this Open Access journal has served as a vital platform for researchers, professionals, and students to disseminate their findings and engage with the latest innovations and discoveries. With an impact factor that reflects its growing influence, GENETICS AND MOLECULAR BIOLOGY ranks in the Q3 category for both genetics and molecular biology as of 2023, indicating its position within the academic community. The journal is indexed in Scopus, highlighting its commitment to maintaining rigorous peer-review standards while providing wide-reaching access to quality research. Operating out of Ribeirão Preto, Brazil, it fosters a collaborative environment for academic discourse and research development not only in Brazil but also globally. The journal encourages submissions that explore a wide range of topics in genetics and molecular biology, making it an essential resource for anyone involved in these dynamic fields.

Plant Biotechnology is a distinguished journal published by the Japanese Society for Plant Cell and Molecular Biology, committed to advancing the field of plant biotechnology through the dissemination of high-quality research. With an ISSN of 1342-4580, this journal caters to a global audience interested in agronomy, crop science, and plant molecular biology. The journal has achieved notable rankings, including Q2 in Agronomy and Crop Science and Q2 in Plant Science, underscoring its relevance and impact in these fields according to the latest 2023 metrics. Furthermore, it holds a respectable position within Scopus rankings across multiple categories, indicating its contribution to the academic community. Although it is not an open-access journal, its regular publications, spanning from 1997 to 2024, feature cutting-edge studies that explore innovative approaches and technologies in plant science. Researchers, professionals, and students will find Plant Biotechnology an essential resource for staying informed on significant advancements and trends in plant research.